Matthew R. Hudson

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Standardization of preclinical methodologies for discovery and validation of circulating microRNA biomarkers for post-traumatic epileptogenesis - Lessons learned from the EpiBioS4Rx Project 1.

Standardization of preclinical methodologies for discovery and validation of circulating microRNA biomarkers for post-traumatic epileptogenesis - Lessons learned from the EpiBioS4Rx Project 1.

Journal: Epilepsy research

Published: August 07, 2025

The impact of response latency on working memory assessment in mice.

The impact of response latency on working memory assessment in mice.

Journal: Experimental neurology

Published: July 27, 2025

Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.

Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: January 02, 2025

Bundle-specific tractography approach for identifying white matter microstructural changes following traumatic brain injury in rats: An EpiBioS4Rx study.

Bundle-specific tractography approach for identifying white matter microstructural changes following traumatic brain injury in rats: An EpiBioS4Rx study.

Journal: Imaging neuroscience (Cambridge, Mass.)

Published: July 31, 2024

Forty-hertz sensory entrainment impedes kindling epileptogenesis and reduces amyloid pathology in an Alzheimer disease mouse model.

Forty-hertz sensory entrainment impedes kindling epileptogenesis and reduces amyloid pathology in an Alzheimer disease mouse model.

Journal: Epilepsia

Published: July 21, 2024

In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730.

In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730.

Journal: Epilepsia

Published: May 21, 2024

Fluoxetine accelerates epileptogenesis and magnifies disease severity in a rat model of acquired epilepsy.

Fluoxetine accelerates epileptogenesis and magnifies disease severity in a rat model of acquired epilepsy.

Journal: Epilepsia

Published: February 27, 2024

Successful harmonization in EpiBioS4Rx biomarker study on post-traumatic epilepsy paves the way towards powered preclinical multicenter studies.

Successful harmonization in EpiBioS4Rx biomarker study on post-traumatic epilepsy paves the way towards powered preclinical multicenter studies.

Journal: Epilepsy research

Published: September 21, 2023

ComBating inter-site differences in field strength: harmonizing preclinical traumatic brain injury MRI data.

ComBating inter-site differences in field strength: harmonizing preclinical traumatic brain injury MRI data.

Journal: NMR in biomedicine

Published: July 05, 2023

Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.

Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.

Journal: International journal of molecular sciences

Published: May 12, 2023

Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist-induced behavioral disruptions in male and female mice.

Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist-induced behavioral disruptions in male and female mice.

Journal: Journal of neuroscience research

Published: May 08, 2023

E2730, an uncompetitive γ-aminobutyric acid transporter-1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy.

E2730, an uncompetitive γ-aminobutyric acid transporter-1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy.

Journal: Epilepsia

Published: March 21, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026